Approximately 70% of all breast cancers are oestrogen-receptor positive (ER+), which means they rely on the hormone oestrogen to grow. As a result, oestrogen-blocking […]
Posts Tagged ‘Tumour’
Has Screening Made a Difference?
Senior executives from CapeRay, the Industrial Development Corporation (IDC) and The Beijing Axis are currently visiting China to explore the globalisation of CapeRay’s […]
A Question of Equipoise
Last week, Etta Pisano, who is chief research officer at the American College of Radiology, sat down for an interview with the […]
Language of Breast Density
Over the years, we have written multiple articles about breast density, including its reduction, legislation, diagnostic challenges and workflow optimization. One may reasonably ask: Why this […]
Tomosynthesis vs Ultrasound in Dense Breasts
A research group based at the University of Genoa in Italy is known by its acronym ASTOUND, which stands for Adjunct […]
Looking for a Polar Bear in a Snowstorm
Fifteen years ago, Nancy Cappello’s annual screening mammogram was found to be normal, just as had been reported for the […]
It’s All About Speed
One of the challenges when imaging the breast is to distinguish benign lesions from those that are malignant. With ultrasound, […]
Google Meets Breast Cancer Challenge
Four years ago Google bought a British artificial intelligence (AI) company called DeepMind for half a billion US dollars. The founders studied […]
Releasing the Brakes on the Immune System
Last week the Nobel Assembly at the Karolinska Institutet in Stockholm awarded the 2018 Nobel Prize in Physiology or Medicine to James […]
NCI Launches Plans for 2020
A decade ago, when CapeRay was still being incubated within the University of Cape Town (UCT), we were successful in […]